ANTHONY H. SALCE, JR.,William F. GREENWOOD,Shivsankar MISIR
申请号：
US15699414
公开号：
US20180064621A1
申请日:
2017.09.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug (NSAID) compound, a calcium channel blocker, an immunosuppressive component, an anti-hypertensive, a hormone, a steroid, and an enzyme inhibitor into a chamber. The methods may comprise milling and mixing the NSAID compound, the calcium channel blocker, the immunosuppressive component, the anti-hypertensive, the hormone, the steroid, and the enzyme inhibitor into a powder. The methods may comprise adding a solvent with the powder. The methods may comprise mixing the solvent with the powder to form the formulation.
